Tag: Research
The short-term impact of 3 smoked cannabis preparations versus placebo on PSTD symptoms: A randomized cross-over clinical trial

Cannabis and cancer part 2: Scientists look for ways to increase knowledge about cannabis with help from people with cancer

Cannabis associated with reduced fentanyl exposure in Vancouver study

Cannabis associated with reduced fentanyl exposure in Vancouver study

Mount Sinai Health System launches Center for Psychedelic Research

The science of addiction: Do you always like the things you want?

DEA issues final rule for licensing more growers of marijuana for research

Psychedelics in Psychiatry — Keeping the renaissance from going off the rails

University at Buffalo and Charlotte’s Web announce collaboration to advance hemp cannabinoid science

UCLA receives seven grants totaling $6.4 million for cannabis research

Peter Thiel backs Berlin start-up making psychedelics in $125 million round

USask launches first study on effects of smoked cannabis on brain development

Mood and cognition after administration of low LSD doses in healthy volunteers

Medical marijuana research gets a boost from Johns Hopkins University and Realm of Caring

Study Designs and Statistical Methods for Studies of Child and Adolescent Health Policies

Cannabis research database shows how U.S. funding focuses on harms of the drug

Like CBD, but better

The Current Status of Psychedelics in Psychiatry

Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review

Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis

FDA action on cannabis firm’s drug for COVID-19 patients sends Philly pharma firm’s stock soaring

The state of cannabis research legislation in 2020

Ethos Cannabis and Jefferson University launch their first studies under Pennsylvania’s Medical Cannabis Research Program

Trump Admin could let researchers study marijuana dispensary products, scientist argues after DOJ memo released

Cannabis scientists are chasing the perfect high

Florida researchers studying COVID-19 impact on marijuana users

Controls to enhance the cultivation of marijuana for research in the United States

White House releases 2020 National Drug Control Strategy

Cannabis compound could be weapon in fight against superbugs

Newfound cannabis compound may be 30 times more potent than THC

WSU partners with California company in hopes of receiving marijuana for research

Insights on the effects of cannabidiol on severe form of epilepsy

The first publicly available annotated genome for cannabis plants

Research Brief: High fat foods can increase CBD absorption into the body

Study will examine prenatal marijuana use on infant development

Hepatotoxicity of a cannabidiol-rich cannabis extract in the mouse model

No, CBD-infused jelly beans definitely won’t get you high. Here’s why.

ABCD study completes enrollment, announces opportunities for scientific engagement

Critics question direction of CSU cannabis research

Cannabis-based drug in combination with other anti-spasticity

Washington issues its first marijuana research license

State issues $2.7 million in medical marijuana research grants

Notice of intent to publish a funding opportunity announcement

Increase in fentanyl — responsible for 44 percent of New York City overdose deaths — has led to apprehension and caution

Federal chokehold on marijuana stymies studies on epilepsy, autism

Scientists explore how marijuana may fight psychosis

Amid opioid crisis, researchers aim to put medical marijuana to test
Study on marijuana and PTSD in military veterans only needs a few more volunteers

Police probe of Brazilian marijuana researcher sparks protests

FDA accepts GW Pharma’s NDA filing for Epidiolex in the treatment of LGS and Dravet syndrome
12/28/17--GW Pharmaceuticals (NASDAQ:GWPH) announces that the FDA has accepted for filing with Priority Review its recently submitted New Drug Application (NDA) for Epidiolex (cannabidiol or CBD), an investigational treatment for seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome, two rare and difficult to treat conditions of childhood-onset epilepsy. The Prescription Drug User Fee Act goal date for completion of the FDA review of the Epidiolex NDA is June 27, 2018. Read
Marijuana may help HIV patients keep mental stamina longer

Could marijuana prevent opioid deaths? Here’s what a UNT researcher says

Meet the ‘father of marijuana research’

Medical marijuana took a bite out of alcohol sales. Recreational pot could take an even bigger one.

Frequency of cannabis use tied to relationship between pain, mood disorders

Synthetic cannabis-like drug reduces sleep apnea

UNM Study: Medical marijuana an alternative for opioids

GW Pharma made an important move with its promising epilepsy treatment Epidiolex

The CannaVan helps marijuana researchers drive around some roadblocks

UF researchers begin study on marijuana as opioid alternative
